ArticleJournal of family medicine and primary care2025
Transformative education: Enhancing pharmacovigilance awareness among healthcare professionals through sensitization initiatives.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects.The Journal of pharmacology and experimental therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacovigilance plays a vital role in patient safety by identifying, assessing, and preventing adverse drug reactions (ADRs). Despite its importance, pharmacovigilance awareness among healthcare professionals often remains limited, leading to underreporting of adverse drug reactions and compromising patient safety. Educational interventions offer a potential solution to enhance pharmacovigilance knowledge and a reporting practice. Aims: To evaluate the effectiveness of an educational intervention in improving knowledge and ADR reporting behaviours among healthcare professionals. Methods and Material: A questionnaire-based pre- and post-intervention design was used, involving health care providers. This study was conducted in three sessions on different dates, with a stipulated time of 2 hour at a tertiary care hospital. Participants attended 2-hour educational session about awareness of pharmacovigilance knowledge, attitude, and practices. A 20-items questionnaire was used to assess about pharmacovigilance awareness before and after educational intervention. Statistical Analysis: Data were analysed using IBM SPSS 27 version software, employing a paired Results: Post-intervention participants had a statistically significant increase in pharmacovigilance knowledge, improved attitude towards ADR reporting, and greater confidence in reporting practices. However, limitations such as the lack of a control group and short follow-up duration suggest that further research is needed to confirm long-term impacts. Conclusions: Educational intervention is effective in enhancing Pharmacovigilance awareness among health care providers. Further studies should include a control group and longer follow-up to better understand the sustained impact of such an intervention. Integrated regular pharmacovigilance training within healthcare institutions and simplifying ADR reporting can further improve medication safety and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.